Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Chronic Myeloid Leukemia
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Leukemia (1944
)
Acute Myelogenous Leukemia (902
)
Acute Lymphocytic Leukemia (389
)
Chronic Lymphocytic Leukemia (292
)
B Acute Lymphoblastic Leukemia (163
)
T Acute Lymphoblastic Leukemia (38
)
Childhood B Acute Lymphoblastic Leukemia (37
)
Hairy Cell Leukemia (19
)
Chronic Myelomonocytic Leukemia (18
)
Prolymphocytic Leukemia (16
)
Acute Promyelocytic Leukemia (12
)
Chronic Eosinophilic Leukemia (4
)
Juvenile Myelomonocytic Leukemia (4
)
Chronic Neutrophilic Leukemia (3
)
Leukemia (1944
)
Acute Myelogenous Leukemia (902
)
Acute Lymphocytic Leukemia (389
)
Chronic Lymphocytic Leukemia (292
)
B Acute Lymphoblastic Leukemia (163
)
T Acute Lymphoblastic Leukemia (38
)
Childhood B Acute Lymphoblastic Leukemia (37
)
Hairy Cell Leukemia (19
)
Chronic Myelomonocytic Leukemia (18
)
Prolymphocytic Leukemia (16
)
Acute Promyelocytic Leukemia (12
)
Chronic Eosinophilic Leukemia (4
)
Juvenile Myelomonocytic Leukemia (4
)
Chronic Neutrophilic Leukemia (3
)
›
Associations
(255)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
dasatinib
Sensitive: A1 - Approval
dasatinib
Sensitive
:
A1
dasatinib
Sensitive: A1 - Approval
dasatinib
Sensitive
:
A1
BCR-ABL1 T315I
Chronic Myeloid Leukemia
BCR-ABL1 T315I
Chronic Myeloid Leukemia
asciminib
Sensitive: A1 - Approval
asciminib
Sensitive
:
A1
asciminib
Sensitive: A1 - Approval
asciminib
Sensitive
:
A1
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
omacetaxine mepesuccinate
Sensitive: A1 - Approval
omacetaxine mepesuccinate
Sensitive
:
A1
omacetaxine mepesuccinate
Sensitive: A1 - Approval
omacetaxine mepesuccinate
Sensitive
:
A1
BCR-ABL1 T315I
Chronic Myeloid Leukemia
BCR-ABL1 T315I
Chronic Myeloid Leukemia
ponatinib
Sensitive: A1 - Approval
ponatinib
Sensitive
:
A1
ponatinib
Sensitive: A1 - Approval
ponatinib
Sensitive
:
A1
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
ponatinib
Sensitive: A1 - Approval
ponatinib
Sensitive
:
A1
ponatinib
Sensitive: A1 - Approval
ponatinib
Sensitive
:
A1
ABL1 T315I
Chronic Myeloid Leukemia
ABL1 T315I
Chronic Myeloid Leukemia
ponatinib
Sensitive: A1 - Approval
ponatinib
Sensitive
:
A1
ponatinib
Sensitive: A1 - Approval
ponatinib
Sensitive
:
A1
Chr t(1;16)(q12;q11.2)
Chronic Myeloid Leukemia
Chr t(1;16)(q12;q11.2)
Chronic Myeloid Leukemia
ponatinib
Sensitive: A1 - Approval
ponatinib
Sensitive
:
A1
ponatinib
Sensitive: A1 - Approval
ponatinib
Sensitive
:
A1
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
busulfan
Sensitive: A1 - Approval
busulfan
Sensitive
:
A1
busulfan
Sensitive: A1 - Approval
busulfan
Sensitive
:
A1
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
asciminib
Sensitive: A1 - Approval
asciminib
Sensitive
:
A1
asciminib
Sensitive: A1 - Approval
asciminib
Sensitive
:
A1
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
nilotinib
Sensitive: A1 - Approval
nilotinib
Sensitive
:
A1
nilotinib
Sensitive: A1 - Approval
nilotinib
Sensitive
:
A1
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
bosutinib
Sensitive: A1 - Approval
bosutinib
Sensitive
:
A1
bosutinib
Sensitive: A1 - Approval
bosutinib
Sensitive
:
A1
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
BCR-ABL1 V299L
Chronic Myeloid Leukemia
BCR-ABL1 V299L
Chronic Myeloid Leukemia
bosutinib
Resistant: A2 - Guideline
bosutinib
Resistant
:
A2
bosutinib
Resistant: A2 - Guideline
bosutinib
Resistant
:
A2
BCR-ABL1 T315I
Chronic Myeloid Leukemia
BCR-ABL1 T315I
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 T315I
Chronic Myeloid Leukemia
BCR-ABL1 T315I
Chronic Myeloid Leukemia
bosutinib
Resistant: A2 - Guideline
bosutinib
Resistant
:
A2
bosutinib
Resistant: A2 - Guideline
bosutinib
Resistant
:
A2
BCR-ABL1 T315I
Chronic Myeloid Leukemia
BCR-ABL1 T315I
Chronic Myeloid Leukemia
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
bosutinib
Sensitive: A2 - Guideline
bosutinib
Sensitive
:
A2
bosutinib
Sensitive: A2 - Guideline
bosutinib
Sensitive
:
A2
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
nilotinib
Sensitive: A2 - Guideline
nilotinib
Sensitive
:
A2
nilotinib
Sensitive: A2 - Guideline
nilotinib
Sensitive
:
A2
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
BCR-ABL1 F317L
Chronic Myeloid Leukemia
BCR-ABL1 F317L
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
Tyrosine kinase inhibitor
Sensitive: A2 - Guideline
Tyrosine kinase inhibitor
Sensitive
:
A2
Tyrosine kinase inhibitor
Sensitive: A2 - Guideline
Tyrosine kinase inhibitor
Sensitive
:
A2
BCR-ABL1 V299L
Chronic Myeloid Leukemia
BCR-ABL1 V299L
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 T315A
Chronic Myeloid Leukemia
BCR-ABL1 T315A
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 F317I
Chronic Myeloid Leukemia
BCR-ABL1 F317I
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 F317V
Chronic Myeloid Leukemia
BCR-ABL1 F317V
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 F317C
Chronic Myeloid Leukemia
BCR-ABL1 F317C
Chronic Myeloid Leukemia
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
dasatinib
Resistant: A2 - Guideline
dasatinib
Resistant
:
A2
BCR-ABL1 Y253H
Chronic Myeloid Leukemia
BCR-ABL1 Y253H
Chronic Myeloid Leukemia
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
BCR-ABL1 E255K
Chronic Myeloid Leukemia
BCR-ABL1 E255K
Chronic Myeloid Leukemia
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
BCR-ABL1 E255V
Chronic Myeloid Leukemia
BCR-ABL1 E255V
Chronic Myeloid Leukemia
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
BCR-ABL1 F359V
Chronic Myeloid Leukemia
BCR-ABL1 F359V
Chronic Myeloid Leukemia
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
BCR-ABL1 F359C
Chronic Myeloid Leukemia
BCR-ABL1 F359C
Chronic Myeloid Leukemia
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
nilotinib
Resistant: A2 - Guideline
nilotinib
Resistant
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login